Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Open-Label Crossover Trial Comparing Tolerability of a Cardioselective Beta-Blocker (Metoprolol-Succinate-ER) and a Non-Cardioselective Beta-Blocker (Carvedilol) in Patients With Chronic Obstructive Pulmonary Disease

NCT03370835 is registered in ClinicalTrials.gov with VA Greater Los Angeles Healthcare System as lead sponsor.

NCT NCT03370835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03370835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Open-Label Crossover Trial Comparing Tolerability of a Cardioselective Beta-Blocker (Metoprolol-Succinate-ER) and a Non-Cardioselective Beta-Blocker (Carvedilol) in Patients With Chronic Obstructive Pulmonary Disease
Lead sponsor
VA Greater Los Angeles Healthcare System
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
June 30, 2008
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of beta-adrenoreceptor antagonists, asthma, pulmonary disease, chronic obstructive